Last reviewed · How we verify
dexmedetomidine-esketamine-ropivacaine combination 2
dexmedetomidine-esketamine-ropivacaine combination 2 is a Small molecule drug developed by Peking University First Hospital. It is currently FDA-approved. Also known as: epidural analgesia using the dexmedetomidine-esketamine-ropivacaine combination 2.
At a glance
| Generic name | dexmedetomidine-esketamine-ropivacaine combination 2 |
|---|---|
| Also known as | epidural analgesia using the dexmedetomidine-esketamine-ropivacaine combination 2 |
| Sponsor | Peking University First Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dexmedetomidine-esketamine-ropivacaine combination 2 CI brief — competitive landscape report
- dexmedetomidine-esketamine-ropivacaine combination 2 updates RSS · CI watch RSS
- Peking University First Hospital portfolio CI
Frequently asked questions about dexmedetomidine-esketamine-ropivacaine combination 2
What is dexmedetomidine-esketamine-ropivacaine combination 2?
dexmedetomidine-esketamine-ropivacaine combination 2 is a Small molecule drug developed by Peking University First Hospital.
Who makes dexmedetomidine-esketamine-ropivacaine combination 2?
dexmedetomidine-esketamine-ropivacaine combination 2 is developed and marketed by Peking University First Hospital (see full Peking University First Hospital pipeline at /company/peking-university-first-hospital).
Is dexmedetomidine-esketamine-ropivacaine combination 2 also known as anything else?
dexmedetomidine-esketamine-ropivacaine combination 2 is also known as epidural analgesia using the dexmedetomidine-esketamine-ropivacaine combination 2.
What development phase is dexmedetomidine-esketamine-ropivacaine combination 2 in?
dexmedetomidine-esketamine-ropivacaine combination 2 is FDA-approved (marketed).
Related
- Manufacturer: Peking University First Hospital — full pipeline
- Also known as: epidural analgesia using the dexmedetomidine-esketamine-ropivacaine combination 2
- Compare: dexmedetomidine-esketamine-ropivacaine combination 2 vs similar drugs
- Pricing: dexmedetomidine-esketamine-ropivacaine combination 2 cost, discount & access